CVS (CVS Health) EBITDA per Share: $8.70 (TTM As of Mar. 2026)


CVS CVS Health Corp CVS
77 GF Score
Price $104.72
GF Value $77.69
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health EBITDA per Share?

CVS Health CVS -0.09% 77 EBITDA per Share is $8.70 as of Mar. 2026. GuruFocus rates CVS with a GF Score™ of 77/100 and a GF Value™ of $77.69 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 16 Healthcare Plans companies, CVS Health ranks worse than 56.25% on this metric.

CVS Health's EBITDA per Share for the three months ended in Mar. 2026 was $4.56. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $8.70.

During the past 12 months, the average EBITDA per Share Growth Rate of CVS Health was -26.00% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -6.00% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -7.60% per year. During the past 10 years, the average EBITDA per Share Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for CVS Health's EBITDA per Share or its related term are showing as below:

CVS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -14.8   Med: 7.8   Max: 26.9
Current: -6

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of CVS Health was 26.90% per year. The lowest was -14.80% per year. And the median was 7.80% per year.

CVS's 3-Year EBITDA Growth Rate is ranked worse than
56.25% of 16 companies
in the Healthcare Plans industry
Industry Median: -2.5 vs CVS: -6.00

CVS Health's EBITDA for the three months ended in Mar. 2026 was $5,827 Mil.

During the past 12 months, the average EBITDA Growth Rate of CVS Health was -24.90% per year. During the past 3 years, the average EBITDA Growth Rate was -7.20% per year. During the past 5 years, the average EBITDA Growth Rate was -8.50% per year. During the past 10 years, the average EBITDA Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of CVS Health was 44.50% per year. The lowest was -16.50% per year. And the median was 8.80% per year.


CVS Health  (NYSE:CVS) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


CVS Health EBITDA per Share Related Terms


CVS Health EBITDA per Share Historical Data

* Premium members only.

The historical data trend for CVS Health's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health EBITDA per Share Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.19 9.33 14.11 10.86 7.76

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.60 2.82 -1.23 2.56 4.56
CVS
77GF Score
CVS Health Corp CVS
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

CVS Health's EBITDA per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA per Share(A: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=9861/1271.000
=7.76

CVS Health's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=5827/1279.000
=4.56

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $8.70 mean?
CVS Health (CVS) has a EBITDA per Share of $8.70 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on CVS Health and its competitors. According to the industry distribution chart, CVS Health ranks #9 out of 16 companies in the Healthcare Plans industry, placing it in the top 56.2%.
Is CVS Health's EBITDA per Share too high?
CVS Health's current EBITDA per Share is $8.70. Based on the distribution chart, CVS Health ranks #9 out of 16 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, CVS Health has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EBITDA per Share compare to ELV and CI?
According to the Healthcare Plans industry distribution chart, CVS Health ranks #9 out of 16 companies for EBITDA per Share. This places CVS Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Healthcare Plans company?
A good EBITDA per Share depends on the Healthcare Plans industry context. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on CVS Health and its competitors. CVS Health's current EBITDA per Share is $8.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is $77.69, compared to a current price of $104.72 — trading 34.8% above its estimated fair value. The current EBITDA per Share is $8.70. CVS Health's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For CVS Health (CVS), the current EBITDA per Share is $8.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of $104.72 is trading 34.8% above its estimated GF Value™ of $77.69. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for CVS:

  • EBITDA per Share: $8.70
  • GF Value™: $77.69 vs. price of $104.72 (34.8% above fair value)
  • GF Score™: 77/100 with 10 warning signs

No single metric tells the full story. See the CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
77GF Score

Get the complete analysis for CVS

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$104.72
Price
$77.69
GF Value